186 related articles for article (PubMed ID: 10471609)
1. The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation.
Dukarm RC; Russell JA; Morin FC; Perry BJ; Steinhorn RH
Am J Respir Crit Care Med; 1999 Sep; 160(3):858-65. PubMed ID: 10471609
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension.
Dukarm RC; Morin FC; Russell JA; Steinhorn RH
Pediatr Res; 1998 Dec; 44(6):831-7. PubMed ID: 9853914
[TBL] [Abstract][Full Text] [Related]
3. Selective type 5 phosphodiesterase inhibition alters pulmonary hemodynamics and lung liquid production in near-term fetal lambs.
Dukarm RC; Steinhorn RH; Russell JA; Lakshminrusimha S; Swartz D; Cummings JJ
J Appl Physiol (1985); 2005 Dec; 99(6):2331-6. PubMed ID: 16123210
[TBL] [Abstract][Full Text] [Related]
4. E4021, a selective phosphodiesterase 5 inhibitor, potentiates the vasodilator effect of inhaled nitric oxide in isolated perfused rat lungs.
Ohnishi M; Oka M; Muramatsu M; Sato K; Kira S; Fukuchi Y
J Cardiovasc Pharmacol; 1999 Apr; 33(4):619-24. PubMed ID: 10218733
[TBL] [Abstract][Full Text] [Related]
5. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
Chester M; Seedorf G; Tourneux P; Gien J; Tseng N; Grover T; Wright J; Stasch JP; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L755-64. PubMed ID: 21856817
[TBL] [Abstract][Full Text] [Related]
6. A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.
Saeki T; Adachi H; Takase Y; Yoshitake S; Souda S; Saito I
J Pharmacol Exp Ther; 1995 Feb; 272(2):825-31. PubMed ID: 7853200
[TBL] [Abstract][Full Text] [Related]
7. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.
Thusu KG; Morin FC; Russell JA; Steinhorn RH
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1605-10. PubMed ID: 7582302
[TBL] [Abstract][Full Text] [Related]
8. Oxidant stress from uncoupled nitric oxide synthase impairs vasodilation in fetal lambs with persistent pulmonary hypertension.
Konduri GG; Bakhutashvili I; Eis A; Pritchard K
Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1812-20. PubMed ID: 17142346
[TBL] [Abstract][Full Text] [Related]
9. Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus.
Ziegler JW; Ivy DD; Fox JJ; Kinsella JP; Clarke WR; Abman SH
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1104-10. PubMed ID: 9563726
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.
Cohen AH; Hanson K; Morris K; Fouty B; McMurty IF; Clarke W; Rodman DM
J Clin Invest; 1996 Jan; 97(1):172-9. PubMed ID: 8550830
[TBL] [Abstract][Full Text] [Related]
11. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phosphodiesterase 1 augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs with acute pulmonary hypertension.
Evgenov OV; Busch CJ; Evgenov NV; Liu R; Petersen B; Falkowski GE; Petho B; Vas A; Bloch KD; Zapol WM; Ichinose F
Am J Physiol Lung Cell Mol Physiol; 2006 Apr; 290(4):L723-L729. PubMed ID: 16284211
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension.
Steinhorn RH; Albert G; Swartz DD; Russell JA; Levine CR; Davis JM
Am J Respir Crit Care Med; 2001 Sep; 164(5):834-9. PubMed ID: 11549542
[TBL] [Abstract][Full Text] [Related]
14. SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension.
Farrow KN; Lakshminrusimha S; Czech L; Groh BS; Gugino SF; Davis JM; Russell JA; Steinhorn RH
Am J Physiol Lung Cell Mol Physiol; 2010 Jul; 299(1):L109-16. PubMed ID: 20400523
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep.
Deruelle P; Grover TR; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L798-806. PubMed ID: 15964898
[TBL] [Abstract][Full Text] [Related]
16. Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide.
Zayek M; Cleveland D; Morin FC
J Pediatr; 1993 May; 122(5 Pt 1):743-50. PubMed ID: 8496755
[TBL] [Abstract][Full Text] [Related]
17. Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs.
Black SM; Johengen MJ; Soifer SJ
Pediatr Res; 1998 Dec; 44(6):821-30. PubMed ID: 9853913
[TBL] [Abstract][Full Text] [Related]
18. Betamethasone attenuates oxidant stress in endothelial cells from fetal lambs with persistent pulmonary hypertension.
Chandrasekar I; Eis A; Konduri GG
Pediatr Res; 2008 Jan; 63(1):67-72. PubMed ID: 18043518
[TBL] [Abstract][Full Text] [Related]
19. Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn.
Wedgwood S; Lakshminrusimha S; Farrow KN; Czech L; Gugino SF; Soares F; Russell JA; Steinhorn RH
Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L616-26. PubMed ID: 22198908
[TBL] [Abstract][Full Text] [Related]
20. Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow.
Reddy VM; Wong J; Liddicoat JR; Johengen M; Chang R; Fineman JR
Am J Physiol; 1996 Aug; 271(2 Pt 2):H562-70. PubMed ID: 8770097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]